載入...
Denosumab for Management of Parathyroid Carcinoma-Mediated Hypercalcemia
CONTEXT: Most of the morbidity and mortality from parathyroid cancer is due to PTH-mediated hypercalcemia. Classically, management mainly consists of surgical resection, chemotherapy, and alleviation of hypercalcemia using bisphosphonates and calcium receptor agonists. The use of denosumab in the tr...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Endocrine Society
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3913820/ https://ncbi.nlm.nih.gov/pubmed/24178790 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2013-3031 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|